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THE EFFECT OF GROUP VOCAL AND SINGING EXERCISES FOR INDIVIDUALS WITH 
PARKINSON’S DISEASE 
 
The majority of individuals with Parkinson’s disease (PD) experience voice and speech 
deficits, collectively called hypokinetic dysarthria; however, treatment outcomes are inconsistent 
and often unsustainable. The purpose of this study was to replicate the music therapy protocol 
for hypokinetic dysarthria (MTPHD) completed by Azekawa and LaGasse (2018) in an effort to 
investigate the effects of a group music therapy treatment for individuals who exhibited voice 
and speech deficits due to PD. The MTPHD consisted of three neurologic music therapy (NMT) 
techniques that specifically target voice and speech characteristics. A total of 17 participants 
with PD completed eight weekly group music therapy sessions. Pretest and posttest 
measurements were documented for three speech assessments to address vocal function, 
vocal quality, articulatory control, and connected speech intelligibility. Significant differences 
were found in vocal quality and the number of inter-word pauses. Positive trends were observed 
in all other measurements, indicating that music therapy may be a viable treatment option to 
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CHAPTER 1: INTRODUCTION 
 
The purpose of this study was to investigate the effects of a group music therapy 
treatment for individuals who exhibited voice and speech deficits due to Parkinson’s disease 
(PD). The treatment consisted of a group music therapy protocol (Music Therapy Protocol for 
Hypokinetic Dysarthria, MTPHD) that was based on three neurological music therapy (NMT) 
techniques to improve voice and speech deficits commonly seen in individuals with PD. These 
deficits include reduced volume of speech, monotone pitch and reduced prosody in speech, 
breathy and hoarse voice quality, imprecise articulation, and varied rate of speech. The study 
examined the effect of MTPHD on vocal/phonatory function, vocal quality, articulatory control, 
and connected speech intelligibility by comparing baseline data and post-treatment data in 
adults with PD. 
Parkinson’s disease (PD) is the second most prevalent neurodegenerative disease after 
Alzheimer’s disease, affecting approximately 1 million people in the U.S. and 10 million 
worldwide (Parkinson’s Foundation, 2020; Parkinson’s Foundation of the National Capital Area, 
2020). PD can be effectively managed with medication, lifestyle choices, and surgery. The 
cause of PD is unknown (Galaz et al., 2016). The risk for developing this disease increases with 
age, with a prevalence rate of approximately 1.5% for people over the age of 65 (Galaz et al., 
2016). In the U.S. alone, the estimated health care costs including treatment, social security, 
and loss of income reach $52 billion per year (Parkinson’s Foundation, 2020). Due to the 
degenerative nature of this disease, persons with PD may be affected on a personal, social, 
and/or economic level, resulting in decreased quality of life. 
Individuals with PD can present with a variety of motor and non-motor deficits, including 
muscular rigidity, tremor, postural instability, and bradykinesia (Anand & Stepp, 2015; Galaz et 
al., 2016; Skodda, 2011). Individuals might present with a weak voice, monotone pitch, difficulty 
initiating speech, or impaired articulation and dysprosody, altogether known as hypokinetic 
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dysarthria, ultimately resulting in decreased speech intelligibility (Galaz et al., 2016; Tjaden & 
Wilding, 2011). An estimated 70% of individuals with PD develop hypokinetic dysarthria 
(Skodda, 2011). This can be one of the earliest signs of PD onset or it may develop as the 
disease progresses (Galaz et al., 2016). Current treatment for hypokinetic dysarthria includes 
speech therapy, pharmacological medication such as levodopa (L-dopa), and sometimes 
surgery (Anand & Stepp, 2015). Although access to these treatments and therapies may be 
available, they come at a high cost and long-term care is not routine for individuals with PD 
(Fogg-Rogers et al., 2016). Yinger and Lapointe (2012) state that fewer than 5% of people with 
PD receive speech treatment, which may indicate a lack of diagnosis for hypokinetic dysarthria, 
ineffective treatment, or a dissatisfaction with long-term results. Researchers have brought forth 
music therapy as an additional treatment option to address voice and speech deficits in persons 
with PD (Azekawa & LaGasse, 2018; Fogg-Rogers et al., 2016). 
         Researchers have promoted music therapy as a viable treatment for speech deficits 
such as dysarthria, dyspraxia, aphasia, dysphonia and dysprosody (Stegemöller, 2017). 
Preferred music is often used in choral or singing programs, alongside Neurologic Music 
Therapy (NMT) techniques, to utilize undamaged neural pathways that may result in speech 
maintenance or improvement (Stegemöller, 2017). Researchers have presented multiple 
protocols to address voice and speech deficits; however, the literature has confounds such as 
small sample sizes, varying speech and neurologic impairments, and irregular protocol content, 
making the findings of these studies difficult to generalize (Fogg-Rogers et al., 2016; Tamplin & 
Baker, 2017). Tamplin & Baker (2017) expressed that, at this time, more replication studies are 
needed to test the existing singing-based therapeutic speech protocols. In a recent study, 
Azekawa & LaGasse (2018) measured differences in vocal function, vocal quality, and 
articulatory control of individuals with PD who were receiving weekly music therapy to address 
voice and speech deficits. The purpose of the present study is to replicate the same protocol in 
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an effort to verify the results of using MTPHD to address speech and language needs for 
individuals with PD. 
The following hypotheses are proposed to investigate the effectiveness of the music 
therapy protocol (MTPHD) to address voice and speech deficits in persons with PD: 
  
1. Music Therapy Protocol for Hypokinetic Dysarthria will produce a pre and posttest difference 
in vocal function of the participants, measured through the duration of sustained vowel 
phonation and vocal tract function steadiness, using the first (f1) and second (f2) formants 
during sustained vowel phonation task as compared to their baseline levels. 
2. Music Therapy Protocol for Hypokinetic Dysarthria will produce a pre and posttest difference 
in vocal quality of the participants, measured through jitter, shimmer, and Harmonics-to-Noise 
Ratio during sustained vowel phonation tasks as compared to their baseline levels. 
3. Music Therapy Protocol for Hypokinetic Dysarthria will produce a pre and posttest difference 
in articulatory control of the participants, measured through the rate of sequenced syllable 
repetitions during diadochokinesis test as compared to the baseline levels. 
4. Music Therapy Protocol for Hypokinetic Dysarthria will produce a pre and posttest difference 
in speech intelligibility of the participants, measured by the number of inter-word pauses and the 
mean duration of the inter-word pauses during the passage reading task as compared to the 
baseline levels.
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CHAPTER 2: LITERATURE REVIEW 
 
Parkinson’s Disease: Overview 
 
The National Institutes of Health (2016) describe the older adult population as a growing 
class of individuals. With this knowledge, the prevalence of Parkinson’s disease (PD) can be 
expected to increase over time. PD is a neurodegenerative disease that currently affects nearly 
1 million individuals in the U.S. (Parkinson’s Foundation, 2020; Parkinson’s Foundation of the 
National Capital Area, 2020), but this slowly progressing disease has a significant impact not 
only on the quality of life for the diagnosed individual, but on their family, friends, and caregivers 
as well. With a prevalence rate of 1% - 2% of individuals over the age of 65 and 3% - 5% of 
individuals over 85 (Fahn, 2003; Galaz et al., 2016), this disease not only affects the individual 
on a personal level, but it affects Americans on a national level. 
PD was first described by the British physician James Parkinson in his work titled An 
essay on the shaking palsy (Parkinson, 1817). The term shaking palsy was used by Parkinson, 
along with other medical professionals at that time, but the disease was renamed by French 
neurologist Jean-Martin Charcot in Parkinson’s honor (Barnett, 2016). In his studies, Parkinson 
observed that the disease, then called “paralysis agitans,” came on gradually, starting with the 
hands and arms and then progressing through the rest of the body (Parkinson, 1817). He 
described six case studies of males over the age of 50 who exhibited symptoms such as tremor, 
stooped posture, reduced muscle control, and irregular gait patterns (Parkinson, 1817). 
Although speech and language symptoms were not the primary focus of his findings, he noted 
that his patients consistently experienced reduced oral motor control and speech intelligibility, 
varied speech rate, and inaccurate articulation (Parkinson, 1817). 
         The most documented symptoms for PD in current literature and James Parkinson’s 
essay are reduced motor control (Martens, Van Nuffelen, Wouters, & De Bodt, 2016; Parkinson, 
1817); however, speech and language deficits have a significant impact on the individual’s 
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communication skills, which can heavily impact quality of life. Roughly 90% of individuals with 
PD develop speech and voice symptoms such as harsh and breathy voice quality, reduced 
vocal loudness and prosody, impaired articulation, irregular speech rate, and overall lack of 
speech intelligibility (Anand & Stepp, 2015; Duffy, 2005; Tanner, Rammage, & Liu, 2016). 
Collectively, these symptoms can be referred to as hypokinetic dysarthria. With approximately 
one-third of modern jobs requiring voice use as a primary tool (Tanner, Rammage, & Liu, 2016; 
Vilkman, 2000), any speech difficulties directly interfere with communication. Therefore, speech 
and voice deficits can have a significant impact on social engagement, psychological well-being 
and economic status (Oxtoby, 1982). 
Neuropathophysiology of Parkinson’s Disease 
         There is currently no cure for PD and the etiology of the disease is unknown. 
Researchers have explored the roles of both environmental factors and genetic predispositions 
and found that they both play important roles in the development of the disease (Bartels & 
Leenders, 2009; Nolte, 2016). This chronic idiopathic disease is characterized by the 
progressive loss of dopaminergic neurons in the basal nuclei, specifically substantia nigra pars 
compacta (SNc) (Galaz et al., 2016). Dopamine carries signals to the brain that are essential for 
typical movement and coordination; therefore, decreased dopamine levels in the brain lead to 
the motor symptoms seen in individuals with PD (Parkinson’s Foundation of the National Capital 
Area, 2020). Basal nuclei are collections of cell bodies deep to the cortex that influence motor 
cortices (Stegemöller, 2017). The most commonly identified basal nuclei include the caudate 
nucleus and putamen (collectively called the striatum), globus pallidus interna (GPi) and globus 
pallidus externa (GPe), nucleus accumbens, subthalamic nucleus, and substantia nigra, which 
is made up of pars compacta (SNc) and pars reticulata (SNr) (Nolte, 2016). 
         The function of the basal nuclei involves motor control and learning. This includes motor 
tasks such as initiation of movement, providing sufficient impetus to see these movements 
executed fully, and attending to postural adjustments prior to movement (Stegemöller, 2017). 
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For movements involved in speech production, the basal nuclei are involved in the 
determination of volume, timing, and sequencing of the voice, movement patterns of the tongue 
and lips, breath control, and speech initiation (Bartels & Leenders, 2009; Murdock & Whelan, 
2009; Stegemöller, 2017). These nuclei are connected to the cortex via paired parallel loops 
that either reinforce or suppress a planned behavior. The direct loop of the motor system 
promotes or reinforces movement, while the indirect loop inhibits movement (Nolte, 2016; 
Stegemöller, 2017). The ability to carry out desired movements and suppress undesirable ones 
requires the normal function of these loops. While there are many sources of input to the loops, 
the dopaminergic axons from the SNc are a particularly critical source of influence that 
facilitates movement. Reduction in dopamine deviates basal nuclei functioning away from 
facilitating movement toward inhibitory movement, resulting in hypokinetic signs associated with 
PD (Bartels & Leenders, 2009; Murdock & Whelan, 2009; Nolte, 2016). Although the basal 
nuclei do not directly issue motor commands, their influence on cortical motor regions are an 
indispensable part of voluntary movement, and their dysfunction can produce a range of 
movement disorders (Nolte, 2016).  
Treatment for Hypokinetic Dysarthria 
While there is currently no treatment to cure PD or stop the progression of the disease, 
researchers have found that symptoms can be managed in a variety of ways. The 
administration of levodopa (L-dopa) was developed in the late 1960s and continues to be a 
successful drug to treat PD (Parkinson’s Foundation, 2020). Over time, it has become the “gold 
standard” therapy for PD (Lane, 2019), as it is synthesized in the brain into dopamine 
(Parkinson’s Foundation, 2020). This drug has the potential to reverse some of the movement 
deficits that are so commonly seen with PD (Nolte, 2016). Although the effects of this 
medication on motor movements have been thoroughly researched, its effect on speech has 
rarely been examined (Skodda, Visser, & Schlegel, 2010). In a 2010 study, researchers 
administered short-term L-dopa and long-term dopaminergic treatment to 23 PD patients and 
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found no significant difference in phonation, intonation, articulation, or speech velocity (Skodda, 
Visser, & Schlegel, 2010). While this treatment has been shown to effectively reduce motor 
symptoms such as rigidity and bradykinesia (Lane, 2019), its ability to address hypokinetic 
dysarthria has not been verified (Skodda, Visser, & Schlegel, 2010). L-dopa may be successful 
for some individuals; however, some patients have experienced a wearing off effect, wherein 
the effect of the medication fluctuates and will unpredictably start and stop working (Parkinson’s 
Foundation, 2020). Dyskinesia (spontaneous, involuntary movements) has also been 
documented as a possible side effect of L-dopa if used over a period of approximately three to 
five years (Lane, 2019; Parkinson’s Foundation, 2020). Surgery is a viable option for individuals 
who have exhausted all other options or who did not respond well to medication.   
There are currently three different surgical treatments that address motor and speech 
symptoms for individuals with PD: deep brain stimulation (DBS), Duopa therapy, and lesion 
therapy (Parkinson’s Foundation, 2020). DBS is an appropriate treatment for people living with 
PD for a minimum of four years and who have motor symptoms that could not be controlled 
through the use of medicine (Parkinson’s Foundation, 2020). This treatment option involves the 
surgical implantation of a battery-operated medical device known as a neurostimulator, to 
distribute electrical stimulation to target areas of the brain that control movement (Parkinson’s 
Foundation, 2020). Typical target areas include the thalamus, subthalamic nucleus, and part of 
the globus pallidus (Parkinson’s Foundation, 2020). DBS has an average motor improvement of 
40% and often decreases the need for medication by about 50%; however, several patients 
have reported mixed evaluations in terms of postoperative satisfaction (Geraedts et al., 2019). 
Risks of this surgery include infection, stroke, cognitive deficits, and reduced speech 
intelligibility (Parkinson’s Foundation, 2020). Furthermore, DBS surgery may not be the right 
treatment for every individual with PD and although studies have shown benefits lasting at least 
five years (Parkinson’s Foundation, 2020), there is still a risk that speech and language 
symptoms may worsen.  
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Duopa therapy is an alternative to the pill form of L-dopa, but this therapy combines L-
dopa with carbidopa (a medication to prevent nausea) and pumps Duopa directly into the 
intestine in gel form (Parkinson’s Foundation, 2020). This treatment has the same side effects 
as L-dopa but it has the potential to improve the fluctuation of motor symptoms.  
Types of lesion therapies include thalamotomy (lesion to the thalamus), pallidotomy 
(lesion to the globus pallidus), and subthalamotomy (lesion to the subthalamus) (Parkinson’s 
Foundation, 2020). After the lesion is created, movement symptoms such as tremor and rigidity 
are expected to improve within a six-week period (Parkinson’s Foundation, 2020). Today, 
doctors rarely perform lesion therapy and furthermore, lesion therapy does not assist with 
speech and language deficits, leaving individuals experiencing hypokinetic dysarthria to seek 
out alternative treatment options (Parkinson’s Foundation, 2020). 
Speech therapy is an additional treatment option that has been shown to be most 
effective for individuals with PD (Yinger & Lapointe, 2012). The Lee Silverman Voice Treatment 
(LSVT)® LOUD is a thoroughly researched approach with positive speech outcomes for 
individuals with PD (LSVT Global, 2020; Ramig, 1992; Tanner, Rammage, & Liu, 2016). This 
approach was developed by Dr. Lorraine Ramig and is used in over 30 countries to treat speech 
disorders for PD (LSVT Global, 2020; Yinger & Lapointe, 2012). This one-month intensive 
protocol emphasizes increasing vocal effort, resulting in increased loudness and pitch variation 
(LSVT Global, 2020; Tanner, Rammage, & Liu, 2016). While this protocol has been thoroughly 
researched, less than 5% of people with PD receive speech treatment (Yinger & Lapointe, 
2012) and research has indicated a lack of carryover and long-term effects of the treatment 
(Ramig, Fox, & Sapir, 2004; Tanner, Rammage, & Liu, 2016; Yinger & Lapointe, 2012). 
Altogether, no single treatment option has demonstrated consistent, long lasting effects to 
address hypokinetic dysarthria in individuals with PD.  
A viable treatment option that researchers have begun to explore more in the past 
decade is the use of music, and more specifically, the use of singing. Singing can naturally 
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intensify various aspects of speech production, making music therapy a viable treatment option 
for hypokinetic dysarthria (Haneishi, 2001; Tanner, Rammage, & Liu, 2016; Yinger & Lapointe, 
2012). The Music Therapy Voice Protocol (MTVP) for PD, drawing on principles from LSVT, 
was developed by Eri Haneishi in an effort to provide a treatment that appropriately addressed 
speech needs for individuals with PD (Haneishi, 2001; Yinger & Lapointe, 2012). MTVP is a 60-
minute protocol for individuals, consisting of an opening and closing conversation, facial and 
breathing warm ups, vocal exercises, singing exercises, practicing sustained vowel sounds, and 
speech exercises (Haneishi, 2001). This protocol focuses on phonation, respiration, speech 
intelligibility, and acoustic parameters as well as overall mood (Haneishi, 2001). In this 2001 
study, statistically significant increases were found in speech intelligibility and vocal intensity 
(Haneishi, 2001). Confounds of this study were the small sample size (N=4), high variability in 
session pretest scores, and lack of a separate control group (Haneishi, 2001). In a later study by 
Haneishi (2006), a larger sample size of 20 individuals with PD were randomly assigned to a 
MTVP treatment group or control group. Speech intelligibility, vocal intensity range, intonation, 
and positive affect showed significant improvement in the MTVP treatment group (Haneishi, 
2006). While the sample size increased for this study, the time frame for data collection and 
variance in session scheduling weakened the validity of the data (Haneishi, 2006). Yinger and 
Lapointe (2012) made a group adaptation for the MTVP (G-MTVP), and the results showed 
significant increases in intensity of conversational speech. Sample size continues to be a 
limitation for many music therapy studies (N=10), along with a lack of a control group. Although 
emerging literature shows promising results for music therapy as a treatment for hypokinetic 
dysarthria, further research with larger sample sizes is necessary before generalizing results. 
Neural Representation of Music Processing  
Music processing is widely distributed in the brain (Thaut, 2005), influencing cognitive, 
affective, and sensorimotor processes (Thaut, McIntosh, & Hoemberg, 2014). Evidence from 
neuroimaging has revealed shared and extended neural networks between singing and speech 
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(Patel, 2003); this can be referred to as the musical and linguistic syntax (Patel, 2003). Maess, 
Koelsch, Gunter, and Friederici (2001) used magnetoencephalography (MEG) to find that 
Broca’s area and its right hemisphere homologue were both involved in the processing of 
musical syntax, indicating a strong relationship between the processing of language and music 
(Patel, 2003). The inferior frontal gyrus, known for its function in speech comprehension, is 
Broca’s area, comprised of Brodmann areas 44 and 45. Another study used functional magnetic 
resonance imaging (fMRI) and found that harmony and language integrate resources in Broca’s 
area (Kunert, Willems, Casasanto, Patel, & Hagoort, 2015). Brown, Martinez, and Parsons 
(2006) used positron emission tomography (PET) to track brain activation in amateur musicians 
while they improvised melodic or linguistic phrases. Results showed that brain areas highlighted 
for both tasks included the primary motor cortex, supplementary motor area, Broca’s area, 
anterior insula, primary and secondary auditory cortices, temporal pole, basal ganglia, ventral 
thalamus, and posterior cerebellum (Brown, Martinez, & Parsons, 2006). This research 
highlights the areas of the brain where music and language processing overlap, indicating that 
music could be a valuable tool to address speech needs in individuals with neurologic 
impairments. 
The effects of rhythmic auditory stimulation (RAS) on motor performance for individuals 
with PD has been documented (Buard, et al., 2019), but using RAS for oral motor entrainment 
has rarely been explored (LaGasse, 2013; Thaut, McIntosh, McIntosh, & Hoemberg, 2001). 
Buard et al. (2019) used MEG to measure motor performance using a finger tapping task with 
RAS, for persons with and without PD. Findings revealed that persons with PD rely more on 
parietal areas of the brain compared to typically functioning older adults. Although this research 
was addressing motor tasks for persons with PD, the neurologic processes involved may be 
correlated with rhythmic speech patterns. Music exercises that mimic speech motor patterns are 
likely to cause neural adaptation that will facilitate positive change in speech accuracy (Tamplin, 
2008).  
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Auditory Rhythmic Entrainment on Speech Motor Control  
 
External auditory cues have been utilized to address speech patterns in persons with PD 
(Thaut, McIntosh, McIntosh, & Hoemberg, 2001), but there has been little research specifically 
addressing oral motor synchronization (LaGasse, 2013). The oral motor system is complex, and 
currently this neurologic process is not fully understood. In a 2013 study, LaGasse used 
kinematics to test oral motor entrainment of the upper lip, lower lip, and jaw for 24 typically 
developing children and adults. Participants repeated the bilabial “pa” in three conditions: 
preferred tempo without a stimulus, preferred tempo with a rhythmic auditory stimulus, and 10% 
faster with a rhythmic auditory stimulus. Results of the Spatiotemporal Index and 
Synchronization Error indicated that external auditory cues can positively influence oral motor 
entrainment (LaGasse, 2013). Priming and cueing of the motor system was observed in this 
current study, as well as previous studies looking at limb motor synchronization (Thaut et al., 
1998). These data indicate that the speech motor process operates similarly to motor 
synchronization of the limbs, implying that these two processes may share neurologic 
representations. These data provide insight into possible shared neural networks and have 
implications for speech rehabilitation for individuals with PD; however, further research should 
be completed to target those who are diagnosed with the disease.  
Neuroscience-based Approaches for Speech Rehabilitation 
 
 Prior research has used neuroscientific findings to inform music therapy protocols to 
address speech intelligibility (LaGasse, 2013; Tamplin, 2008; Tamplin & Baker, 2017; Thaut, 
McIntosh, McIntosh, & Hoemberg, 2001). Neurologic music therapy (NMT) “focuses on music 
as a biological language whose structural elements, sensory attributes, and expressive qualities 
engage the human brain comprehensively and in a complex manner,” (Thaut, McIntosh, & 
Hoemberg, 2014, p. 6). A handful of music therapy protocols have been developed to 
specifically address speech needs in individuals with aphasia, dysarthria, dyspraxia, stroke, 
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traumatic brain injury (TBI), and degenerative speech disorders such as PD (Stegemöller, 2017; 
Tamplin & Baker, 2017), but few have used neuroscience-based approaches (Azekawa & 
LaGasse, 2018; Tamplin, 2008). Tamplin (2008) completed a pilot study to explore the effects of 
NMT techniques on speech intelligibility and naturalness in individuals with dysarthria following 
a TBI or stroke. Results indicated significant improvements in speech intelligibility and 
naturalness. Yinger and Lapointe (2012) adapted Tamplin’s music therapy voice protocol 
(MTVP) for a group (G-MTVP) of individuals with PD. Results from this study showed significant 
improvements in intensity of conversational speech. Research addressing hypokinetic 
dysarthria is persons with PD (Azekawa & LaGasse, 2018; Di Benedetto et al., 2009; Elefant et 
al., 2012, Evans et al., 2012; Haneishi, 2001; Perez-Delgado, 2007, Yinger & Lapointe, 2012) 
has indicated that neuroscience based approaches have the potential to positively impact 
speech needs in persons with PD; however, further research needs to be completed with larger 
sample sizes, and replication studies are needed to test the current music therapy protocols 
(Tamplin & Baker, 2017). 
The three NMT techniques used in in Tamplin (2008), Yinger and Lapointe (2012), and 
Azekawa and LaGasse’s (2018) research included 1) Oral Motor and Respiratory Exercises 
(OMREX), 2) Vocal Intonation Therapy (VIT), and 3) Therapeutic Singing (TS). Through the use 
of sound vocalization exercises, OMREX can be applied to address articulatory control and 
respiratory strength (Mertel, 2014). These exercises elicit a neurologic response, causing the 
individual to exert conscious control over an automatic function such as breath cycle (Tamplin, 
2008). VIT utilizes vocal exercise that incorporate musical elements such as inflection, pitch, 
breath control, timbre, and dynamics to address aspects of voice control that are damaged 
(Thaut, 2014). In a 2001 study, Haneishi found improvements in vocal intensity after participants 
with PD completed 14, 60-minute music therapy sessions to address hypokinetic dysarthria. 
Perez-Delgado (2007) adapted this protocol for Spanish speakers and found improvements in 
breath control, voluntary speech production, and vocal loudness. TS is often integrated with 
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OMREX and VIT to use singing activities for therapeutic purposes (Johnson, 2014). Studies 
have found that group singing has been known to increase speech intelligibility, overall mood, 
and vocal intensity (Haneishi, 2001; Perez-Delgado, 2007), and decrease pause time (Azekawa 
& LaGasse, 2018). 
Altogether, researchers have clearly demonstrated that a large population of individuals 
with PD experience hypokinetic dysarthria along with a variety of motor deficits; however, music 
therapy treatment options lack consistent efficacy and need to be replicated before results can 
be generalized. While recent literature has correlated neurologic findings with music therapy 
techniques used to address speech, only a handful of music therapy protocols implement this 
knowledge (Azekawa & LaGasse, 2018; Tamplin, 2008). Replication studies are necessary to 
investigate what music therapy techniques and protocols are most successful in addressing 





CHAPTER 3: METHODS 
 
This study is replicating the music therapy protocol (Music Therapy Protocol for 
Hypokinetic Dysarthria, MTPHD) used in a recent study completed by Azekawa & LaGasse 
(2018). 
Participants: 
Participants were recruited from a local PD support group that was held in the University 
Center for the Arts (UCA) at Colorado State University, Fort Collins, CO. The study was 
approved by the Institutional Review Board of Colorado State University. Seventeen individuals 
(2 females, 15 males) participated in the study. Five participants did not complete the study due 
to absences. 
The inclusion criteria were current diagnosis of Parkinson's disease with the severity of 
the disease determined by Hoehn & Yahr scale (Hoehn & Yahr, 1967) from 1 to 3 according to 
their self-reports as recorded by the research team. Participants were native English speakers 
and exhibited one or more characteristics of hypokinetic dysarthria including reduced volume of 
speech, monotone pitch, reduced stress in speech pattern, breathy and hoarse voice quality, 
imprecise articulation, and varied rate of speech. All participants were over the age of 46, and 
the onset of PD was after 46 years of age. The mean age (standard deviation) of the 
participants was 66.1 (8.989) years and their mean Hoehn and Yahr scale rating was 2.7 
(0.393). Informed consent was obtained from all participants before beginning the study. 
The exclusion criteria were individuals who were currently receiving music therapy 
treatment addressing voice and speech deficits. Since Parkinson's disease affects people over 
the age of 50, minors were not included. The participants were not diagnosed with any other 






Baseline Characteristics Mean (SD) 
Age 66.06 (8.99) 
H & Y 2.68 (0.39) 
 
Measurement Instruments: 
Participants completed a pretest and posttest of three speech tasks to assess: (a) vocal 
function and voice quality (sustained vowel phonation task), (b) articulatory control ability 
(diadochokinesis test), and (c) connected speech intelligibility (Rainbow Passage Reading). The 
audio samples were recorded using the Edirol R-09HR 24-bit/96KHz WAV/MP3 Recorder 
manufactured by Roland to assure accurate and reliable audio recording for data analyses. The 
recorded data was then transferred into spectrogram by a vocal signal analysis software PRAAT 
(Boersma & Weekink, 2019), which was installed in Apple MacBook Pro. 
1. Sustained Vowel Phonation Task. 
Vocal (Phonatory) Function Assessment. Phonation is the process in which the vocal 
folds vibrate to create sound (The National Center for Voice and Speech, 2019). Individuals with 
PD may experience abnormal vocal fold vibration resulting in poor vocal quality and increased 
vocal fatigue (Baken & Orlikoff, 2000). At least 50% of people with PD present with vocal fold 
bowing (lack of medial vocal fold closure), as well as asymmetrical vibratory patterns, laryngeal 
tremors, and insufficient glottal closure (Baken & Orlikoff, 2000; Elefant, Baker, Lotan, Lagesen, 
& Skeie, 2012). The duration measurement of sustained vowel phonation has been used in 
previous studies (Di Benedetto et al., 2009; Haneishi, 2001) to explain glottal function that 
affects vocal phonation (Azekawa & LaGasse, 2018). This measurement also indicates 
steadiness of vocal tract functioning, which can be expressed in variances of the first formant 
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(f1) and second formant (f2). Formants are a series of resonances created by the vocal tract 
and their varying frequencies are directly related to the changing shape of the vocal tract 
(Azekawa & LaGasse, 2018; Nair, 1999; Sataloff, 2005). The mandible, tongue, lips, larynx, and 
the side walls of the pharynx are moving articulators that can influence the shape of the vocal 
tract (Azekawa & LaGasse, 2018; Sataloff, 2005). The first two formants, f1 and f2 are 
specifically influenced by the opening of the mandible as well as the tongue shape; these are 
both required for the sustained vowel phonation assessment (Azekawa & LaGasse, 2018; Nair, 
1999; Sataloff, 2005). 
Voice Quality Assessment. Jitter and shimmer are significant acoustic descriptions of 
the abnormalities in voice quality that have been measured in previous music therapy and PD 
research (Adams & Dykstra, 2009; Azekawa & LaGasse, 2018; Di Benedetto et al., 2009). 
These measurements are indicators of the distress level in the vocal sound for acoustic 
analyses (Adams & Dykstra, 2009; Azekawa & LaGasse, 2018). Specifically, jitter describes 
cycle-to-cycle variation in frequency and shimmer describes cycle-to-cycle variation in amplitude 
(Adams & Dykstra, 2009; Azekawa & LaGasse, 2018; Kent & Ball, 2000). Any measurements 
for jitter above 1.040% and shimmer above 3.810% are considered in the PRAAT program as 
above threshold of pathology (Azekawa, 2011; Boersma & Weenink, 2010). Abnormal 
increments of these two factors create sounds of “harshness” in the voice (Azekawa & 
LaGasse, 2018; Laver, Hiller, & Beck, 1992).    
Harmonics-to-Noise Ratio (HNR) is another acoustic index that refers to the proportion 
of vocal sound to noise ratio; lower HNR scores indicate more noise in the voice (Azekawa & 
LaGasse, 2018; Forrest & Weismer, 2009). Measurements of HNR at 20 dB or below are 








Jitter, Shimmer, and the Harmonics-to-Noise Ratio - Threshold of Pathology 
 
Threshold of Pathology 
Jitter (%) 
   
> 1.040 % 
Shimmer (%) 
   
> 3.810 % 
Harmonics-to-Noise Ratio (dB) 
   
< 20 dB 
 
2. Diadochokinesis Test for Articulatory Control Assessment 
The diadochokinesis test uses three monosyllables /pa/, /ta/, /ka/ as a sequence to test 
articulatory control (Azekawa & LaGasse, 2018; Kent, Kent, & Rosenbek, 1987). Participants 
were asked to select or alternate their place for syllabic productions with similar voiced stops 
within a five second period. This enabled the assessment of speech motor control without the 
influence of language production since the assessment test only involved repetitions of 
monosyllables (Azekawa & LaGasse, 2018; Padovani, Gielow, & Behlau, 2009).  
3. Rainbow Passage Reading Task for Inter-word Pause Assessment  
The Rainbow Passage reading task is another speech test that has been used in 
previous PD research (Stepp, 2013) to assess connected speech intelligibility. This piece of text 
contains all vowel and consonant sounds in the English language and is available on public 
domain (Fairbanks, 1960, p. 127). The first paragraph of the Rainbow Passage contains 35 
words and was used for the pretest and posttest measurements for all participants. During each 
test, all participants were asked to read the entire paragraph aloud; however, only the third and 
fourth sentences of each paragraph were used for data analyses.  
Inter-word pauses (i.e. pauses between words) were assessed by measuring the 
number of inter-word pauses, and the duration of each inter-word pause. Duration of inter-word 
pauses was determined by spectrogram analysis as greater than 200 milliseconds (Kent, Kent, 
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& Rosembek, 1987; Van Nuffele, Bodt, Vanderwegen, de Heyning, & Wuyts, 2010). Irregular 
number and duration measurements affects rate of speech and might be related to speech 
prosody (Azekawa, 2011; Duffy, 2005; Skodda & Schlegel, 2008). Any pause that was recorded 
between the end of the third sentence and the beginning of the fourth sentence was excluded 
from the analysis.  
Altogether, these speech tasks reveal information that is essential when examining voice 
and speech characteristics for individuals with PD. Results from these assessments will 
contribute to the effectiveness of the MTPHD.  
Design 
The research design replicated the pilot study completed by Azekawa (2011) using a 
one group pretest posttest design. As indicated in Azekawa (2011), the MTPDH was the 
independent variable, and the dependent variables included the following three speech 
measures: (a) sustained vowel phonation task, which measured the duration of the sustained 
vowel phonation, the mean of the first (f1) and second (f2) formants for vocal function, the 
percentages of jitter and shimmer, and the Harmonic-to-Noise Ratio (HNR) for vocal quality, (b) 
the diadochokinesis test, which measured the number of sequenced syllable repetitions for 
articulatory control, and (c) Rainbow Passage reading task, which measured the number of 
inter-word pauses, and the mean duration of inter-word pause time for connected speech 
intelligibility. 
Procedures 
Recruitment flyers were approved by the Institutional Review Board and distributed to 
participants in a PD exercise group that took place at the UCA. Individuals who were interested 
in participating in the study responded to the researcher by phone or email to set up an 
appointment to complete the pretest. Prior to completing the pretest, each participant was 
assigned a number to ensure anonymity. Informed consent was acquired from each participant 
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and then a pre-study questionnaire was distributed. The questionnaire addressed information 
regarding the participants musical preferences as well as their past and present level of 
involvement with music. Results of the questionnaire were used to select preferred music for the 
singing exercises. An in-person interview was also completed in order to obtain general 
information such as age and PD onset from the participants. Following the questionnaire and 
interview, participants were given three speech tasks for a pretest measurement. Data were 
recorded and securely stored. Within the week following the pretest, participants began group 
music therapy sessions lasting 50-minutes for a total of six weeks (i.e. six sessions). In these 
sessions, a board-certified music therapist used the MTPHD. Each participant took the posttest 
within a week after the last session. Both the pretest and posttest took place at the UCA. 
Music Therapy Protocol for Hypokinetic Dysarthria (MTPHD) 
MTPHD is a protocol designed by Azekawa and LaGasse (2018) for individuals with PD 
who display characteristics of hypokinetic dysarthria. MTPHD is based on three Neurologic 
Music Therapy techniques: Vocal Intonation Therapy (VIT), Therapeutic Singing (TS), and Oral 
Motor and Respiratory Exercises (OMREX). Azekawa and LaGasse (2018) used OMREX 
techniques in their treatment protocol but did not explicitly state that the OMREX was being 
used. The protocol was delivered over a six-week period of time in which the participants 
attended weekly group music therapy sessions. Each session was approximately 50 minutes, 
consisting of a 5-minute opening/relaxation exercise, a 15-minute vocal warm-up, two 10-minute 
singing exercises, and a 5-minute closing/relaxation exercise, with a 5-minute water break in the 
middle of the session. Sessions were facilitated by a board-certified music therapist with 15 
years of experience and advanced training in neurologic music therapy, using piano 
accompaniments and verbal instructions, along with PowerPoint slides for visual cues. All 
participants were seated in chairs during each session. All sessions were comprised of the 
following activities:  
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Opening/Movement Exercises  
The 50-minute sessions began with the music therapist explaining the purpose of the 
session, the role of the music therapist, and the targeted goals and objectives. Next, the music 
therapist led the group in a warmup exercise, completing simple motor movements such as toe 
taps, heel lifts, and marching to decrease muscle tension. 
Oral Motor and Respiratory Exercises (OMREX) and Therapeutic Singing (TS) 
OMREX was used to lead a series of vocal exercises addressing articulatory control and 
respiratory strength. Certain consonant, vowel, and syllabic sounds were repeated within the 
context of singing. After the completion of these exercises, participants would sing through a 
preferred song that addressed the targeted areas. For example, the participants would first 
practice forming vowels, and then would sing through the song “Witch Doctor” to practice 
articulatory control within words.  
Water Break 
A cup of water was distributed by the facilitator to all participants who were interested. 
This was done in an effort to prevent dry mouth or sore throat, and to give the group time to rest 
their voice.  
Vocal Intonation Therapy (VIT) and Therapeutic Singing (TS) 
VIT was used to lead a series of vocal exercises addressing respiratory control, 
improving phonatory controls, and expanding vocal prosody or pitch range. After the completion 
of these exercises, participants would sing through a preferred song that addressed the targeted 
areas. For example, the participants were prompted to sing an entire phrase of a song in one 
breath in order to practice respiratory control.  
Closing Exercises 
The session ended with a farewell song and cool down exercises where the music 
therapist facilitated movements such as neck stretches, shoulder/arm extensions, and deep 
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breathing to release any muscle tension. The music therapist reviewed key points highlighted in 
each exercise and acknowledged the participants for their hard work. All participants were 
reminded of the next session date and time and then a few minutes were left for participants to 
ask any additional questions. 
Data Analysis 
A board-certified music therapist, who was also trained in vocal analysis, completed 
acoustic analyses on spectrograms and waveforms that were displayed in the PRAAT vocal 
analysis software program. PRAAT is the name of the program and Dutch for “speak” (Azekawa 
& LaGasse, 2018). A spectrogram is a graphic representation of sound in time and frequency, 
and a waveform displays a shape of a sound in a given period of time (Azekawa, 2011). The X 
axis on the graph represents time and the Y axis represents frequency. The color of the lines 
represents amplitude and each horizontal band or group of lines represents a different harmonic 
in the sound spectrum (The National Center for Voice and Speech, 2019). The program 
provided a visual representation for the duration of the sustained vowel phonation, the mean of 
the first (f1) and second (f2) formants, jitter, shimmer, and the HNR of the voiced sound from the 
sustained vowel phonation audio samples. Additionally, PRAAT provided a visual representation 
for the number of syllable repetitions from the diadochokinesis test audio samples and the 
presence and duration of each inter-word pause from the Rainbow Passage audio samples. 
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CHAPTER 4: RESULTS 
 
 The data were analyzed using the Microsoft Excel data analysis package. A paired 
samples t-test was used to determine whether there was a significant difference between 
pretest and posttest data among all of the participants for voice and speech parameters. An 
alpha level of 0.05 was used as the threshold for two-tailed significance. The parameters 
included vocal function, vocal quality, articulatory control, and inter-word pauses. Due to the 
small sample size, significant results were verified using a Wilcoxon signed ranks test. 
Vocal Function Assessment 
 Results of a paired samples t-test comparing the pretest and posttest data for vocal 
function variables is presented in Table 3. 
Sustained Vowels 
 Pretest and posttest measurements for each participant’s duration of sustained vowel 
phonation showed that the majority of participants increased their duration time; however, 
Participant 11 improved their duration by 52%. A paired samples t-test that compared pretest 
and posttest data for vocal functions is shown in Table 1. The mean for sustained vowel 
duration increased from 14.3 (SD = 6.72) seconds to 15.18 (SD = 6.84) seconds; however, 
results showed no significant changes between pretest and posttest measurements. 
Formant Measures 
Outcome measurements for the mean are displayed in Figures 2. The majority of 
participants increased in Hz for both measurements; however, Participant 16 demonstrated a 
large decrease in the first formant (f1) while Participant 6 demonstrated a large increase in the 
second formant (f2). Although the mean for the first formant (f1) and second formant (f2) 














Pretest                  Posttest t(16) p (2-tailed) Cohen's d 
Mean (SD) Mean (SD)    
The Duration of 
Sustained Vowel 
Phonations (s) 14.3 (6.72) 15.18 (6.84) -1.15 0.27 0.13 
Mean f1 (Hz) 667.95 (119.56) 688.28 (86.56) -0.72 0.48 0.2 






Figure 2. Changes in the Mean of the First (f1) and Second Formant (f2) 
 
Vocal Quality Assessment 
 Results of a paired samples t-test comparing the pretest and posttest data for voice 
quality variables is presented in Table 4. 
Jitter 
 The overall mean for jitter measurements decreased from pretest (M = 0.49; SD = 0.58) 
to posttest (M = 0.33; SD = 0.75); however, the results did not indicate a significant difference. A 
decrease indicates vocal quality improvement. 
Shimmer 
 A significant difference was found (t(16) = 2.62, p = 0.05), indicating a decrease from 
pretest (M = 4.84; SD = 4.04) to posttest (M = 2.3; SD = 3.49). A decrease indicates vocal 
quality improvement.  
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Harmonic to Noise Ratio (HNR) 
 The overall mean for HNR measurements increased from pretest (M = 17.8; SD = 3.63) 
to posttest (M = 18.1; SD = 4.49); however, the results did not indicate a significant difference. 
An increase indicates vocal quality improvement. 
Table 4 
 
Results of a Paired Samples t-Test Measuring Vocal Quality 
 
Dependent Variables Pretest             Posttest t(16) p (2-tailed) Cohen's d 
Mean (SD) Mean (SD)    
Jitter (%) 0.49 (0.58) 0.33 (0.75) 1.49 0.16 0.25 
Shimmer (%) 4.84 (4.04) 2.3 (3.49) 2.62 0.02 0.67 
Harmonics-to-Noise (dB) 17.8 (3.63) 18.1 (4.49) -0.34 0.74 0.07 
Note: Thresholds 
 




Figure 4. Changes in the Mean for Harmonics-to-Noise Ratio 
Articulatory Control Assessment 
 The results of a paired samples t-test for the diadochokinesis test comparing pretest and 
posttest measurements is shown in Table 5. No significant differences were found. The majority 
of participants required less time during the posttest to complete 10 repetitions of the /pa/ /ta/ 
/ka/ syllable series and participants were able to complete more repetitions of the series within 
five seconds during the posttest. 
Connected Speech Inter-Word Pause Assessment 
 The results of the paired samples t-test comparing pretest and posttest measurements 
for inter-word pauses is shown in Table 6. A significant difference was found in the number of 
pauses (t(16) = -2.17, p = 0.05); indicating that the pause time increased from pretest (M=0.41; 








Figure 6. Results of Diadochokinesis Test for the Mean Frequency of Repetitions in 5 Seconds 
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Table 5  
 
Results of a Paired Samples t-Test for Diadochokinesis Test 
 
 
Dependent Variables Pretest               Posttest t(16) p (2-tailed) Cohen’s d 
 Mean (SD) Mean (SD)    
Time needed for 10 
repetitions 7.86 (4.74) 6.99 (2.93) 1.15 0.27 0.22 
Frequency of repetitions 




Figure 7. Results of Mean for Inter-word Pause Count 
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Results of a Paired Samples t-Test for Inter-word Pauses 
 
Dependent Variables Pretest             Posttest 
 
t(16) p (2-tailed) Cohen's d 
Mean (SD) Mean (SD)    
Number of Pauses 0.41 (0.51) 0.94 (1.25) -2.17 0.05 -0.55 
Duration of Pauses (s) 0.2 (0.38) 0.2 (0.27) 0.03 0.98 0.01 
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CHAPTER 5: DISCUSSION 
 
The purpose of this study was to replicate the music therapy protocol for hypokinetic 
dysarthria (MTPHD) completed by Azekawa and LaGasse (2018) in an effort to investigate the 
effects of a group music therapy treatment for individuals who exhibited voice and speech 
deficits due to Parkinson’s disease (PD). Although there were few statistically significant 
changes in the dependent variables, there were positive changes observed within most 
participants. This indicates that music therapy may be a viable treatment option to address 
voice and speech needs in people with PD.  
Participants had statistically significant changes from pretest to posttest for shimmer and 
number of inter-word pauses; however, the number of inter-word pauses increased which was 
an unfavorable outcome. In Azekawa and LaGasse’s (2018) study, results were contrary to the 
current study, with findings that shimmer increased (meaning vocal quality decreased) and the 
number of inter-word pauses decreased/improved (approaching significance). This difference 
could be due to the larger sample size difference in the current study (N = 17), compared to (N 
= 5) in Azekawa and LaGasse’s (2018) study. A larger sample size for both studies would 
minimize variability in the mean scores and provide a better representation of the population. It 
should also be noted that the participants of this study read the same paragraph of the Rainbow 
Passage during pretest and posttest, while the participants in Azekawa and LaGasse’s (2018) 
study read the second paragraph during the posttest.  
The descriptive data indicate that, while not significant, there were changes in pre to 
posttest scores for participants in the study. Twelve out of the 17 participants improved their 
duration of sustained vowel phonations. Participant 11 made the most progress for duration, 
increasing their duration by 52%. Positive trends were also observed in the first formant (f1) and 
second formant (f2), a small indication of what this positive trend was. A look at these measures 
shows that some participants improved in some measures and regressed in others. For 
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example, although Participant 16 made progress during sustained vowel phonation, they 
regressed in both formant measurements. Changes in f1 relate to the openness of the mandible 
while changes in f2 are influenced by the shape of the tongue (Azekawa & LaGasse, 2018; Nair, 
1999; Sataloff, 2005). While these mouth and tongue positions are both essential for sustained 
vowel phonation, an individual would still be able to sustain a vowel with a restricted or 
otherwise less open oral position. Although PD is a neurodegenerative disease, individuals 
demonstrated positive trends towards improved or maintained vocal function.  
Results from vocal quality measures of jitter, shimmer, and HNR displayed mixed results 
among participants. These findings are consistent with the results from Azekawa and LaGasse’s 
(2018) study. For example, Participants 1 and 16 showed a large increase in both jitter and 
shimmer, while Participants 2 and 15 showed a large decrease. Participant 16 surpassed the 
threshold of pathology in their posttest measurements for both jitter and shimmer, and 
conversely, Participant 2 had jitter and shimmer measurements that were both below the 
threshold of pathology during posttest. The majority of participants demonstrated a reduction in 
HNR, indicating a decline in vocal quality; however, Participant 5 had a pretest score of 21.28 
that then increase during posttest measurements to 26.31, indicating vocal quality improvement.  
Overall, articulatory control improved after posttest showing continued positive trends. 
The majority of participants required less time to complete 10 repetitions and were also able to 
complete more repetitions of the syllable series within a five second duration. Outliers included 
Participant 7 who demonstrated a 34% increase in time needed to complete 10 repetitions and 
a 29% decrease in frequency of repetitions in five seconds. Contextual factors might have 
played a role in these mixed results due to the fact that only a handful of participants 
demonstrated reduced articulatory control during posttest measurements. The time of day and 
previous use of their voice during that day may have had a negative effect.  
Limitations of the present study include a small sample size and lack of a control group 
for comparison. Out of the 17 participants, only two were female which is not representative of 
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PD, even though men are 1.5 times more likely to have the disease (Parkinson’s Foundation, 
2020). The participants were chosen from a convenience sample and there was no 
randomization. Additionally, throughout the study medication changes were recorded but were 
not used as a variable of consideration. This was a replication study based off of the protocol 
used in Azekawa and LaGasse’s (2018) study. While this study increased in sample size and 
overall treatment length, expanding from six weeks to eight weeks, it was completed in the 
same state and at the same University. This limits external validity because the contextual 
characteristics remained constant throughout both studies.  
Future replication studies should further explore this protocol along with other music 
therapy voice protocols that specifically address hypokinetic dysarthria in individuals with PD. 
Studies completed at varying locations with larger sample sizes and control groups would be 
more representative of this population and would add to the validity and efficacy of the study. 
Additional areas for this population that have been explored in research (Elefant et al., 2012, 
Evans et al., 2012; Haneishi, 2001; Perez-Delgado, 2007) include quality of life, mood, and 
socialization. These topic areas would be beneficial to explore in research protocols that 
implement group treatment.  
 In conclusion, this replication study showed varying results from the original study 
completed by Azekawa and LaGasse in 2018. Some measures were consistent, such as vocal 
quality measures, while others varied, such as shimmer and number of inter-word pauses. 
These mixed results should encourage future researchers to replicate existing protocols as they 
are needed in our field (Tamplin & Baker, 2017). This study showed positive trends towards 
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